SCORE2-diabetes : 10-year cardiovascular risk estimation in type 2 diabetes in Europe
- Author
- [missing] SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration, Lisa Pennells, Stephen Kaptoge, Helena Bleken Østergaard, Stephanie H Read, Fabrizio Carinci, Josep Franch-Nadal, Carmen Petitjean, Owen Taylor, Steven H J Hageman, Zhe Xu, Fanchao Shi, Sarah Spackman, Stefano Gualdi, Naomi Holman, Rui Bebiano Da Providencia E Costa, Fabrice Bonnet, Hermann Brenner, Richard F Gillum, Stefan Kiechl, Deborah A Lawlor, Louis Potier, Ben Schöttker, Reecha Sofat, Henry Völzke, Johann Willeit, Zane Baltane, Stephen Fava, Sandor Janos, Astrid Lavens, Santa Pildava, Tamara Poljicanin, Ivan Pristas, Peter Rossing, Reiff Sascha, Christa Scheidt-Nave, Iztok Stotl, Gail Tibor, Vilma Urbančič-Rovan, An-Sofie Vanherwegen, Dorte Vistisen, Yong Du, Matthew R Walker, Peter Willeit, Brian Ference, Dirk De Bacquer (UGent) , Martin Halle, Radu Huculeci, John William McEvoy, Adam Timmis, Panagiotis Vardas, Jannick A N Dorresteijn, Ian Graham, Angela Wood, Björn Eliasson, William Herrington, John Danesh, Dídac Mauricio, Massimo Massi Benedetti, Naveed Sattar, Frank L J Visseren, Sarah Wild, Emanuele Di Angelantonio, Beverley Balkau, Fabrice Bonnet, Frederic Fumeron, Hannah Stocker, Bernd Holleczek, Sabine Schipf, Carsten Oliver Schmidt, Marcus Dörr, Herbert Tilg, Christoph Leitner, Marlene Notdurfter, Julie Taylor, Caroline Dale, David Prieto-Merino, Richard F Gillum, Astrid Lavens, An-Sofie Vanherwegen, Tamara Poljicanin, Ivan Pristas, Tamara Buble, Pero Ivanko, Peter Rossing, Bendix Carstensen, Christin Heidemann, Yong Du, Christa Scheidt-Nave, Tibor Gall, Janos Sandor, Zane Baltane, Santa Pildava, Jana Lepiksone, Caroline J Magri, Joseph Azzopardi, Iztok Stotl, Jordi Real, Bogdan Vlacho and Manel Mata-Cases
- Organization
- Abstract
- Aims To develop and validate a recalibrated prediction model (SCORE2-Diabetes) to estimate the 10-year risk of cardiovascular disease (CVD) in individuals with type 2 diabetes in Europe. Methods and results SCORE2-Diabetes was developed by extending SCORE2 algorithms using individual-participant data from four large-scale datasets comprising 229 460 participants (43 706 CVD events) with type 2 diabetes and without previous CVD. Sex-specific competing risk-adjusted models were used including conventional risk factors (i.e. age, smoking, systolic blood pressure, total, and HDL-cholesterol), as well as diabetes-related variables (i.e. age at diabetes diagnosis, glycated haemoglobin [HbA1c] and creatinine-based estimated glomerular filtration rate [eGFR]). Models were recalibrated to CVD incidence in four European risk regions. External validation included 217 036 further individuals (38 602 CVD events), and showed good discrimination, and improvement over SCORE2 (C-index change from 0.009 to 0.031). Regional calibration was satisfactory. SCORE2-Diabetes risk predictions varied several-fold, depending on individuals' levels of diabetes-related factors. For example, in the moderate-risk region, the estimated 10-year CVD risk was 11% for a 60-year-old man, non-smoker, with type 2 diabetes, average conventional risk factors, HbA1c of 50 mmol/mol, eGFR of 90 mL/min/1.73 m(2), and age at diabetes diagnosis of 60 years. By contrast, the estimated risk was 17% in a similar man, with HbA1c of 70 mmol/mol, eGFR of 60 mL/min/1.73 m(2), and age at diabetes diagnosis of 50 years. For a woman with the same characteristics, the risk was 8% and 13%, respectively. Conclusion SCORE2-Diabetes, a new algorithm developed, calibrated, and validated to predict 10-year risk of CVD in individuals with type 2 diabetes, enhances identification of individuals at higher risk of developing CVD across Europe.
- Keywords
- Cardiology and Cardiovascular Medicine, Cardiovascular diseases, Diabetes, Prediction model
Downloads
-
diab.pdf
- full text (Published version)
- |
- open access
- |
- |
- 1.09 MB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-01HA7EYZ8XHWW81WDEKMQVNAN9
- MLA
- SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration, [missing], et al. “SCORE2-Diabetes : 10-Year Cardiovascular Risk Estimation in Type 2 Diabetes in Europe.” EUROPEAN HEART JOURNAL, vol. 44, no. 28, Oxford University Press (OUP), 2023, pp. 2544–56, doi:10.1093/eurheartj/ehad260.
- APA
- SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration, [missing], Pennells, L., Kaptoge, S., Østergaard, H. B., Read, S. H., Carinci, F., … Mata-Cases, M. (2023). SCORE2-diabetes : 10-year cardiovascular risk estimation in type 2 diabetes in Europe. EUROPEAN HEART JOURNAL, 44(28), 2544–2556. https://doi.org/10.1093/eurheartj/ehad260
- Chicago author-date
- SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration, [missing], Lisa Pennells, Stephen Kaptoge, Helena Bleken Østergaard, Stephanie H Read, Fabrizio Carinci, Josep Franch-Nadal, et al. 2023. “SCORE2-Diabetes : 10-Year Cardiovascular Risk Estimation in Type 2 Diabetes in Europe.” EUROPEAN HEART JOURNAL 44 (28): 2544–56. https://doi.org/10.1093/eurheartj/ehad260.
- Chicago author-date (all authors)
- SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration, [missing], Lisa Pennells, Stephen Kaptoge, Helena Bleken Østergaard, Stephanie H Read, Fabrizio Carinci, Josep Franch-Nadal, Carmen Petitjean, Owen Taylor, Steven H J Hageman, Zhe Xu, Fanchao Shi, Sarah Spackman, Stefano Gualdi, Naomi Holman, Rui Bebiano Da Providencia E Costa, Fabrice Bonnet, Hermann Brenner, Richard F Gillum, Stefan Kiechl, Deborah A Lawlor, Louis Potier, Ben Schöttker, Reecha Sofat, Henry Völzke, Johann Willeit, Zane Baltane, Stephen Fava, Sandor Janos, Astrid Lavens, Santa Pildava, Tamara Poljicanin, Ivan Pristas, Peter Rossing, Reiff Sascha, Christa Scheidt-Nave, Iztok Stotl, Gail Tibor, Vilma Urbančič-Rovan, An-Sofie Vanherwegen, Dorte Vistisen, Yong Du, Matthew R Walker, Peter Willeit, Brian Ference, Dirk De Bacquer, Martin Halle, Radu Huculeci, John William McEvoy, Adam Timmis, Panagiotis Vardas, Jannick A N Dorresteijn, Ian Graham, Angela Wood, Björn Eliasson, William Herrington, John Danesh, Dídac Mauricio, Massimo Massi Benedetti, Naveed Sattar, Frank L J Visseren, Sarah Wild, Emanuele Di Angelantonio, Beverley Balkau, Fabrice Bonnet, Frederic Fumeron, Hannah Stocker, Bernd Holleczek, Sabine Schipf, Carsten Oliver Schmidt, Marcus Dörr, Herbert Tilg, Christoph Leitner, Marlene Notdurfter, Julie Taylor, Caroline Dale, David Prieto-Merino, Richard F Gillum, Astrid Lavens, An-Sofie Vanherwegen, Tamara Poljicanin, Ivan Pristas, Tamara Buble, Pero Ivanko, Peter Rossing, Bendix Carstensen, Christin Heidemann, Yong Du, Christa Scheidt-Nave, Tibor Gall, Janos Sandor, Zane Baltane, Santa Pildava, Jana Lepiksone, Caroline J Magri, Joseph Azzopardi, Iztok Stotl, Jordi Real, Bogdan Vlacho, and Manel Mata-Cases. 2023. “SCORE2-Diabetes : 10-Year Cardiovascular Risk Estimation in Type 2 Diabetes in Europe.” EUROPEAN HEART JOURNAL 44 (28): 2544–2556. doi:10.1093/eurheartj/ehad260.
- Vancouver
- 1.SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration [missing], Pennells L, Kaptoge S, Østergaard HB, Read SH, Carinci F, et al. SCORE2-diabetes : 10-year cardiovascular risk estimation in type 2 diabetes in Europe. EUROPEAN HEART JOURNAL. 2023;44(28):2544–56.
- IEEE
- [1][missing] SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration et al., “SCORE2-diabetes : 10-year cardiovascular risk estimation in type 2 diabetes in Europe,” EUROPEAN HEART JOURNAL, vol. 44, no. 28, pp. 2544–2556, 2023.
@article{01HA7EYZ8XHWW81WDEKMQVNAN9,
abstract = {{Aims To develop and validate a recalibrated prediction model (SCORE2-Diabetes) to estimate the 10-year risk of cardiovascular disease (CVD) in individuals with type 2 diabetes in Europe. Methods and results SCORE2-Diabetes was developed by extending SCORE2 algorithms using individual-participant data from four large-scale datasets comprising 229 460 participants (43 706 CVD events) with type 2 diabetes and without previous CVD. Sex-specific competing risk-adjusted models were used including conventional risk factors (i.e. age, smoking, systolic blood pressure, total, and HDL-cholesterol), as well as diabetes-related variables (i.e. age at diabetes diagnosis, glycated haemoglobin [HbA1c] and creatinine-based estimated glomerular filtration rate [eGFR]). Models were recalibrated to CVD incidence in four European risk regions. External validation included 217 036 further individuals (38 602 CVD events), and showed good discrimination, and improvement over SCORE2 (C-index change from 0.009 to 0.031). Regional calibration was satisfactory. SCORE2-Diabetes risk predictions varied several-fold, depending on individuals' levels of diabetes-related factors. For example, in the moderate-risk region, the estimated 10-year CVD risk was 11% for a 60-year-old man, non-smoker, with type 2 diabetes, average conventional risk factors, HbA1c of 50 mmol/mol, eGFR of 90 mL/min/1.73 m(2), and age at diabetes diagnosis of 60 years. By contrast, the estimated risk was 17% in a similar man, with HbA1c of 70 mmol/mol, eGFR of 60 mL/min/1.73 m(2), and age at diabetes diagnosis of 50 years. For a woman with the same characteristics, the risk was 8% and 13%, respectively. Conclusion SCORE2-Diabetes, a new algorithm developed, calibrated, and validated to predict 10-year risk of CVD in individuals with type 2 diabetes, enhances identification of individuals at higher risk of developing CVD across Europe.}},
author = {{SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration, [missing] and Pennells, Lisa and Kaptoge, Stephen and Østergaard, Helena Bleken and Read, Stephanie H and Carinci, Fabrizio and Franch-Nadal, Josep and Petitjean, Carmen and Taylor, Owen and Hageman, Steven H J and Xu, Zhe and Shi, Fanchao and Spackman, Sarah and Gualdi, Stefano and Holman, Naomi and Da Providencia E Costa, Rui Bebiano and Bonnet, Fabrice and Brenner, Hermann and Gillum, Richard F and Kiechl, Stefan and Lawlor, Deborah A and Potier, Louis and Schöttker, Ben and Sofat, Reecha and Völzke, Henry and Willeit, Johann and Baltane, Zane and Fava, Stephen and Janos, Sandor and Lavens, Astrid and Pildava, Santa and Poljicanin, Tamara and Pristas, Ivan and Rossing, Peter and Sascha, Reiff and Scheidt-Nave, Christa and Stotl, Iztok and Tibor, Gail and Urbančič-Rovan, Vilma and Vanherwegen, An-Sofie and Vistisen, Dorte and Du, Yong and Walker, Matthew R and Willeit, Peter and Ference, Brian and De Bacquer, Dirk and Halle, Martin and Huculeci, Radu and McEvoy, John William and Timmis, Adam and Vardas, Panagiotis and Dorresteijn, Jannick A N and Graham, Ian and Wood, Angela and Eliasson, Björn and Herrington, William and Danesh, John and Mauricio, Dídac and Benedetti, Massimo Massi and Sattar, Naveed and Visseren, Frank L J and Wild, Sarah and Di Angelantonio, Emanuele and Balkau, Beverley and Bonnet, Fabrice and Fumeron, Frederic and Stocker, Hannah and Holleczek, Bernd and Schipf, Sabine and Schmidt, Carsten Oliver and Dörr, Marcus and Tilg, Herbert and Leitner, Christoph and Notdurfter, Marlene and Taylor, Julie and Dale, Caroline and Prieto-Merino, David and Gillum, Richard F and Lavens, Astrid and Vanherwegen, An-Sofie and Poljicanin, Tamara and Pristas, Ivan and Buble, Tamara and Ivanko, Pero and Rossing, Peter and Carstensen, Bendix and Heidemann, Christin and Du, Yong and Scheidt-Nave, Christa and Gall, Tibor and Sandor, Janos and Baltane, Zane and Pildava, Santa and Lepiksone, Jana and Magri, Caroline J and Azzopardi, Joseph and Stotl, Iztok and Real, Jordi and Vlacho, Bogdan and Mata-Cases, Manel}},
issn = {{0195-668X}},
journal = {{EUROPEAN HEART JOURNAL}},
keywords = {{Cardiology and Cardiovascular Medicine,Cardiovascular diseases,Diabetes,Prediction model}},
language = {{eng}},
number = {{28}},
pages = {{2544--2556}},
publisher = {{Oxford University Press (OUP)}},
title = {{SCORE2-diabetes : 10-year cardiovascular risk estimation in type 2 diabetes in Europe}},
url = {{http://doi.org/10.1093/eurheartj/ehad260}},
volume = {{44}},
year = {{2023}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: